Evidence map›Paper›PMID 35994394›Full record

ArticleClinical and translational medicine2022

Serglycin-induced interleukin-1β from oesophageal cancer cells upregulate hepatocyte growth factor in fibroblasts to promote tumour angiogenesis and growth.

Dongdong Yan, Di Cui, Yun Zhu, Cecilia Ka Wing Chan, Chung Hang Jonathan Choi, Tengfei Liu, Sai Wah Tsao, Stephanie Ma, Annie Lai Man Cheung

Erratum issuedOpen access · goldAbstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Dongdong YanSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, SAR, China.ORCID 0000-0002-9250-9562
Di CuiSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, SAR, China.
Yun ZhuCenter for Clinical Big Data and Analytics, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Cecilia Ka Wing ChanDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Hong Kong, SAR, China.
Chung Hang Jonathan ChoiDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Hong Kong, SAR, China.
Tengfei LiuSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, SAR, China.
Sai Wah TsaoSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, SAR, China.
Stephanie MaSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, SAR, China.
Annie Lai Man CheungSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, SAR, China.ORCID 0000-0003-3217-1456
University of Hong Kong · HKChinese University of Hong Kong · HKSecond Affiliated Hospital of Zhejiang University · CNUniversity of Hong Kong - Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Esophageal NeoplasmsHepatocyte Growth FactorFibroblastsHumansInterleukin-1betaNeovascularization, PathologicProteoglycansVesicular Transport ProteinsHepatocyte Growth FactorInterleukin-1betaProteoglycansserglycinVesicular Transport Proteins

Identifiers

PMID35994394
PMCPMC9394751
OpenAlexW4292641153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.